# US 2022/0024986 A1 · Molecular signature generation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0024986 A1
- Document ID: US20220024986A1
- Status: Published application
- Kind: A1
- Application number: 17/342,938
- Filed: 2021-06-09
- Published: 2022-01-27
- Earliest claimed: 2020-06-09
- Assignees: OpenNano, Inc.
- Applicants: OpenNano, Inc.
- Inventors: Kim E. Drexler; Serge Faguet; Ashwin Gopinath; Vadim Pinskiy; Tj Brunette; George Markou
- Web page: https://patentgrep.com/patent/US20220024986A1

## CPC

- C07K 14/001: {by chemical synthesis}
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C07K 2319/40: containing a tag for immunodetection, or an epitope for immunisation
- C12Q 2563/185: Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
- G06N 3/02: Neural networks
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS

## Abstract

The present invention provides bi-stable functionalized organic molecule and methods of utilizing these bi-stable functionalized organic molecule.

## Claims

### Claim 1

A bi-stable functionalized organic molecule (functionalized gadget), the bi-stable functionalized organic molecule comprises:
(a) two structurally rigid, constant regions (constant region 1 and constant region 2);
(b) two modifiable, variable regions (variable region 1 and variable region 2);
(c) a purification tag;
(d) a barcode region; and
wherein variable region 1 is covalently attached to an interior position or a terminal position of constant region 2, constant region 2 is covalently attached to an interior position or a terminal position of constant region 1, variable region 2 is covalently attached to an interior position or a terminal position of constant region 1, the purification tag is attached to an interior position of constant region 2; and the barcode region is covalently attached to an interior position or a terminal position of variable region 1 or variable region 2;
wherein the variable region 1 and variable region 2 interact through intermolecular hydrogen bonding, zwitterionic bonding, or a combination of intermolecular hydrogen bonding and zwitterionic bonding.

### Claim 2 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein variable region 1 or variable region 2 of the bi-stable functionalized organic molecule interacts with a target analyte and undergoes a conformational change.

### Claim 3 (depends on 2)

The bi-stable functionalized organic molecule of claim 2, wherein the interaction removes a portion of the intermolecular hydrogen bonding, zwitterionic bonding, or a combination of the intermolecular hydrogen bonding and zwitterionic bonding in the bi-stable functionalized organic molecule and reveals the purification tag.

### Claim 4 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein the barcode region comprises a nucleic acid.

### Claim 5 (depends on 4)

The bi-stable functionalized organic molecule of claim 4, wherein the nucleic acid comprise 20 base pairs of nucleotides to about 5000 base pairs of nucleotides.

### Claim 6 (depends on 4)

The bi-stable functionalized organic molecule of claim 4, wherein the nucleic acid comprise natural nucleotides, unnatural nucleotides, synthetic nucleotides, or combinations thereof.

### Claim 7 (depends on 4)

The bi-stable functionalized organic molecule of claim 4, wherein the nucleic acid comprises DNA, RNA, or a combination of DNA and RNA.

### Claim 8 (depends on 6)

The bi-stable functionalized organic molecule of claim 6, wherein the nucleic acid comprises RNA.

### Claim 9 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein variable region 1 and variable region 2 comprise a structured set of peptides, an unstructured set of peptides, or a combination of a structured set of peptides and an unstructured set of peptides.

### Claim 10 (depends on 9)

The bi-stable functionalized organic molecule of claim 9, wherein the structured set of peptides or unstructured set of peptides comprise from about 3 amino acids to about 100 amino acids.

### Claim 11 (depends on 10)

The bi-stable functionalized organic molecule of claim 10, wherein the amino acids comprise L-amino acids, D-amino acids, nonstandard unnatural amino acids, amino acid analogs, or a combination thereof.

### Claim 12 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein constant region 1 and constant region 2 comprise sequences of amino acids.

### Claim 13 (depends on 12)

The bi-stable functionalized organic molecule of claim 12, wherein the constant region 1 and constant region 2 comprise from about 3 amino acids to about 200 amino acids.

### Claim 14 (depends on 13)

The bi-stable functionalized organic molecule of claim 13, wherein the amino acids comprise L-amino acids, D-amino acids, nonstandard unnatural amino acids, amino acid analogs, or a combination thereof.

### Claim 15 (depends on 12)

The bi-stable functionalized organic molecule of claim 12, wherein the constant region 1, constant region 2, or combinations of constant region 1 and constant region 2 further comprise sites for covalent attachments.

### Claim 16 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein the purification tag is a protein tag or a peptide tag.

### Claim 17 (depends on 14)

The bi-stable functionalized organic molecule of claim 14, wherein the purification tag may comprise a single site or multiple sites for external covalent attachments.

### Claim 18 (depends on 1)

The bi-stable functionalized organic molecule of claim 1, wherein the bi-stable functionalized organic molecule is an amino acid sequence from SEQ ID NOs 1 to 36.

### Claim 19 (depends on 16)

The bi-stable functionalized organic molecule of claim 16, wherein the bi-stable functionalized organic molecule is an amino acid sequence from SEQ ID NOs 3, 11, 14, 21, 27, or 35.

### Claim 20 (depends on 2)

The bi-stable functionalized organic molecule of claim 2, wherein the target analyte comprises a protein, a small molecule, a metabolite, or a combination of two or more thereof.
